Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Scarpellini

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Frontiers in Medicine|May 13, 2022
The Apparent Asymmetrical Relationship Between Small Bowel Bacterial Overgrowth, Endotoxemia, and Liver Steatosis and Fibrosis in Cirrhotic and Non-Cirrhotic Patients: A Single-Center Pilot StudyE Scarpellini, L Abenavoli, V Cassano, et al.
Alimentary Pharmacology & Therapeutics|June 21, 2005
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowthE C Lauritano, M Gabrielli, A Lupascu, et al.
European Review for Medical and Pharmacological Sciences|June 9, 2009
Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazoleE C Lauritano, M Gabrielli, E Scarpellini, et al.
European Review for Medical and Pharmacological Sciences|February 26, 2020
Effects of enteral nutrition on patients with pressure lesions: a single center, pilot studyG Stracci, E Scarpellini, E Rinninella, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Frontiers in Medicine|May 13, 2022
The Apparent Asymmetrical Relationship Between Small Bowel Bacterial Overgrowth, Endotoxemia, and Liver Steatosis and Fibrosis in Cirrhotic and Non-Cirrhotic Patients: A Single-Center Pilot StudyE Scarpellini, L Abenavoli, V Cassano, et al.
Alimentary Pharmacology & Therapeutics|June 21, 2005
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowthE C Lauritano, M Gabrielli, A Lupascu, et al.
European Review for Medical and Pharmacological Sciences|June 9, 2009
Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazoleE C Lauritano, M Gabrielli, E Scarpellini, et al.
European Review for Medical and Pharmacological Sciences|February 26, 2020
Effects of enteral nutrition on patients with pressure lesions: a single center, pilot studyG Stracci, E Scarpellini, E Rinninella, et al.
Pageof 4